Back
Royal Caribbean Group Vs. Avidity Biosciences Industry Stock Comparison
Buy
64
RCL
Royal Caribbean Group
Last Price:
$211.90
Seasonality Move:
6.34%
Sell
34
RNA
Avidity Biosciences
Last Price:
$31.10
Seasonality Move:
-10.33%
Buy
64
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
-
The current Royal Caribbean Group [RCL] share price is $207.90. The Score for RCL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $32.13. The Score for RNA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $207.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCL is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $32.13The current trend is relatively stagnant and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
RCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.89 | Sell |
Relative Strength Index (14 RSI): | 31 | Sell |
Chaikin Money Flow: | -3263220 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.06 - 263.64) | Sell |
Bollinger Bands (100): | (215.42 - 253.82) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 54.74 | Buy |
Chaikin Money Flow: | -1849074 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.71 - 33.63) | Buy |
Bollinger Bands (100): | (29.46 - 43.3) | Sell |
RCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 218.93 | Sell |
20-day SMA: | 237.87 | Sell |
50-day SMA: | 241.42 | Sell |
200-day SMA: | 198.02 | Buy |
8-day EMA: | 217.75 | Sell |
20-day EMA: | 231.5 | Sell |
50-day EMA: | 237.47 | Sell |
200-day EMA: | 203.74 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.29 | Buy |
20-day SMA: | 30.97 | Buy |
50-day SMA: | 30.96 | Buy |
200-day SMA: | 38.58 | Sell |
8-day EMA: | 30.89 | Buy |
20-day EMA: | 30.96 | Buy |
50-day EMA: | 32.21 | Sell |
200-day EMA: | 34.03 | Sell |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.92 per share, a decrease next quarter of $2.85 per share, an increase this year of $3.21 per share, and an increase next year of $2.71 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.57 per share.
Royal Caribbean Group Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |